annual shareholders equity:
$163.31M+$171.52M(+2089.14%)Summary
- As of today (September 17, 2025), CDTX annual stockholders equity is $163.31 million, with the most recent change of +$171.52 million (+2089.14%) on December 31, 2024.
- During the last 3 years, CDTX annual shareholders equity has risen by +$141.74 million (+657.00%).
- CDTX annual shareholders equity is now at all-time high.
Performance
CDTX Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$501.17M+$359.49M(+253.73%)Summary
- As of today (September 17, 2025), CDTX quarterly stockholders equity is $501.17 million, with the most recent change of +$359.49 million (+253.73%) on June 30, 2025.
- Over the past year, CDTX quarterly shareholders equity has increased by +$370.24 million (+282.76%).
- CDTX quarterly shareholders equity is now at all-time high.
Performance
CDTX quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CDTX Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2089.1% | +282.8% |
| 3 y3 years | +657.0% | +6395.4% |
| 5 y5 years | +331.6% | +1112.0% |
CDTX Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1231.1% | at high | +2918.8% |
| 5 y | 5-year | at high | +1231.1% | at high | +2918.8% |
| alltime | all time | at high | +1231.1% | at high | +2918.8% |
CDTX Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $501.17M(+253.7%) |
| Mar 2025 | - | $141.68M(-13.2%) |
| Dec 2024 | $163.31M(-2089.1%) | $163.31M(+41.2%) |
| Sep 2024 | - | $115.63M(-11.7%) |
| Jun 2024 | - | $130.94M(-836.4%) |
| Mar 2024 | - | -$17.78M(+116.6%) |
| Dec 2023 | -$8.21M(-43.1%) | -$8.21M(-202.1%) |
| Sep 2023 | - | $8.04M(-47.9%) |
| Jun 2023 | - | $15.41M(-42.6%) |
| Mar 2023 | - | $26.84M(-285.9%) |
| Dec 2022 | -$14.44M(-166.9%) | -$14.44M(-259.2%) |
| Sep 2022 | - | $9.07M(-213.9%) |
| Jun 2022 | - | -$7.96M(-260.6%) |
| Mar 2022 | - | $4.96M(-77.0%) |
| Dec 2021 | $21.57M(+101.3%) | $21.57M(-1963.0%) |
| Sep 2021 | - | -$1.16M(-107.3%) |
| Jun 2021 | - | $15.79M(+734.5%) |
| Mar 2021 | - | $1.89M(-82.3%) |
| Dec 2020 | $10.71M(-71.7%) | $10.71M(-63.7%) |
| Sep 2020 | - | $29.55M(-28.5%) |
| Jun 2020 | - | $41.35M(-23.1%) |
| Mar 2020 | - | $53.75M(+42.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $37.84M(-36.0%) | $37.84M(-22.7%) |
| Sep 2019 | - | $48.96M(+54.1%) |
| Jun 2019 | - | $31.78M(-27.5%) |
| Mar 2019 | - | $43.86M(-25.8%) |
| Dec 2018 | $59.14M(-1.0%) | $59.14M(-15.4%) |
| Sep 2018 | - | $69.93M(-14.9%) |
| Jun 2018 | - | $82.14M(+61.3%) |
| Mar 2018 | - | $50.92M(-14.8%) |
| Dec 2017 | $59.74M(-32.2%) | $59.74M(+18.1%) |
| Sep 2017 | - | $50.57M(-17.5%) |
| Jun 2017 | - | $61.26M(-19.4%) |
| Mar 2017 | - | $75.99M(-13.8%) |
| Dec 2016 | $88.18M(-15.1%) | $88.18M(+19.3%) |
| Sep 2016 | - | $73.92M(-12.8%) |
| Jun 2016 | - | $84.81M(-10.8%) |
| Mar 2016 | - | $95.08M(-8.5%) |
| Dec 2015 | $103.91M(+392.4%) | $103.91M(-7.7%) |
| Sep 2015 | - | $112.63M(-6.8%) |
| Jun 2015 | - | $120.86M(+112.2%) |
| Mar 2015 | - | $56.94M(+169.8%) |
| Dec 2014 | $21.10M(-1609.5%) | $21.10M |
| Dec 2013 | -$1.40M | - |
FAQ
- What is Cidara Therapeutics, Inc. annual stockholders equity?
- What is the all time high annual shareholders equity for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual shareholders equity year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly shareholders equity year-on-year change?
What is Cidara Therapeutics, Inc. annual stockholders equity?
The current annual shareholders equity of CDTX is $163.31M
What is the all time high annual shareholders equity for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual stockholders equity is $163.31M
What is Cidara Therapeutics, Inc. annual shareholders equity year-on-year change?
Over the past year, CDTX annual stockholders equity has changed by +$171.52M (+2089.14%)
What is Cidara Therapeutics, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of CDTX is $501.17M
What is the all time high quarterly shareholders equity for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly stockholders equity is $501.17M
What is Cidara Therapeutics, Inc. quarterly shareholders equity year-on-year change?
Over the past year, CDTX quarterly stockholders equity has changed by +$370.24M (+282.76%)